1. ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIAL. (11th November 2019) Authors: Cassady, Kevin; Miller, Katherine; Prasad, Nripesh; Maric, Dragan; Bernstock, Josh; Roth, Justin; Barker, Naomi; Coleman, Jennifer; Schieffer, Kathleen; Leraas, Kristen; Miller, Anthony; Leavenworth, Jianmei; Cutter, Gary; Whitley, Richard; Roizman, Bernard; Yancey Gillespie, G; Mardis, Elaine; M... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. H-102 The detente between herpes simplex viruses and their human host. (April 2018) Authors: Roizman, Bernard Journal: Journal of acquired immune deficiency syndromes Issue: Volume 77(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19. Issue 10226 (7th March 2020) Authors: Calisher, Charles; Carroll, Dennis; Colwell, Rita; Corley, Ronald B; Daszak, Peter; Drosten, Christian; Enjuanes, Luis; Farrar, Jeremy; Field, Hume; Golding, Josie; Gorbalenya, Alexander; Haagmans, Bart; Hughes, James M; Karesh, William B; Keusch, Gerald T; Lam, Sai Kit; Lubroth, Juan; Mackenzie,... Journal: Lancet Issue: Volume 395:Issue 10226(2020) Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗